NO20014845D0 - Use of arylalkanoylpyridazines - Google Patents

Use of arylalkanoylpyridazines

Info

Publication number
NO20014845D0
NO20014845D0 NO20014845A NO20014845A NO20014845D0 NO 20014845 D0 NO20014845 D0 NO 20014845D0 NO 20014845 A NO20014845 A NO 20014845A NO 20014845 A NO20014845 A NO 20014845A NO 20014845 D0 NO20014845 D0 NO 20014845D0
Authority
NO
Norway
Prior art keywords
arylalkanoylpyridazines
Prior art date
Application number
NO20014845A
Other languages
Norwegian (no)
Other versions
NO20014845L (en
Inventor
Jonas Rochus
Michael Wolf
Norbert Beier
Franz-Werner Kluxen
Claus Fittschen
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014845D0 publication Critical patent/NO20014845D0/en
Publication of NO20014845L publication Critical patent/NO20014845L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20014845A 1999-04-06 2001-10-05 Use of arylalkanoylpyridazines NO20014845L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19915364A DE19915364A1 (en) 1999-04-06 1999-04-06 Use of arylalkanoylpyridazines
PCT/EP2000/002280 WO2000059484A2 (en) 1999-04-06 2000-03-15 Use of arylalkanoylpyridazines

Publications (2)

Publication Number Publication Date
NO20014845D0 true NO20014845D0 (en) 2001-10-05
NO20014845L NO20014845L (en) 2001-10-05

Family

ID=7903583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014845A NO20014845L (en) 1999-04-06 2001-10-05 Use of arylalkanoylpyridazines

Country Status (18)

Country Link
EP (1) EP1143944A3 (en)
JP (1) JP2002541095A (en)
KR (1) KR20020000550A (en)
CN (1) CN1355702A (en)
AR (1) AR023261A1 (en)
AU (1) AU3811600A (en)
BR (1) BR0009549A (en)
CA (1) CA2367051A1 (en)
CZ (1) CZ20013598A3 (en)
DE (1) DE19915364A1 (en)
HU (1) HUP0200311A3 (en)
ID (1) ID30381A (en)
MX (1) MXPA01010034A (en)
NO (1) NO20014845L (en)
PL (1) PL350963A1 (en)
RU (1) RU2001129703A (en)
WO (1) WO2000059484A2 (en)
ZA (1) ZA200109120B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040087335A (en) * 2002-03-01 2004-10-13 야마노우치세이야쿠 가부시키가이샤 Nitrogen-Containing Heterocyclic Compound
DE10224888A1 (en) * 2002-06-05 2003-12-24 Merck Patent Gmbh pyridazine
DE10225574A1 (en) * 2002-06-10 2003-12-18 Merck Patent Gmbh New 1-acyl-3-phenyl-5,6-dihydro-4H-pyridazine derivatives, are phosphodiesterase IV inhibitors useful e.g. for treating asthma, allergy, inflammation, autoimmune diseases or myocardial diseases
EP1640010A1 (en) * 2003-07-01 2006-03-29 Astellas Pharma Inc. Agent inducing increase in bone mass
CL2008001933A1 (en) * 2007-06-29 2009-09-25 Millennium Pharm Inc Pyrimidine derived compounds, raph kinase inhibitors; intermediate compounds; preparation procedure; pharmaceutical composition; and its use to treat proliferative, cardiac, neurodegenerative, inflammatory, bone, immunological, viral disease, among others.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19632549A1 (en) * 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazines
DE19826841A1 (en) * 1998-06-16 1999-12-23 Merck Patent Gmbh Arylalkanoylpyridazines
DE19850701A1 (en) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoyl pyridazines
DE19915365A1 (en) * 1999-04-06 2000-10-12 Merck Patent Gmbh Tetrahydropyridazine derivatives

Also Published As

Publication number Publication date
HUP0200311A2 (en) 2002-11-28
DE19915364A1 (en) 2000-10-12
MXPA01010034A (en) 2002-04-24
EP1143944A2 (en) 2001-10-17
ID30381A (en) 2001-11-29
CA2367051A1 (en) 2000-10-12
BR0009549A (en) 2002-03-26
PL350963A1 (en) 2003-02-24
WO2000059484A3 (en) 2001-08-23
AU3811600A (en) 2000-10-23
HUP0200311A3 (en) 2002-12-28
EP1143944A3 (en) 2002-09-11
WO2000059484A2 (en) 2000-10-12
JP2002541095A (en) 2002-12-03
CZ20013598A3 (en) 2002-01-16
RU2001129703A (en) 2004-02-20
KR20020000550A (en) 2002-01-05
ZA200109120B (en) 2003-11-13
AR023261A1 (en) 2002-09-04
CN1355702A (en) 2002-06-26
NO20014845L (en) 2001-10-05

Similar Documents

Publication Publication Date Title
ID26056A (en) DIAPON ONCE USE
ID26389A (en) DIAPON ONCE USE
NO20022979D0 (en) Use of organic compounds
NO20014379D0 (en) Use of Xenon for the Treatment of Neurointoxics
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
ID30233A (en) ANTIBIOTICS OF TETOLIDA
ID25571A (en) DIAPON ONCE USE
ID24782A (en) DIAPON ONCE USE
NO20041968L (en) Use of cystationin
PT1022396E (en) COMBINATION OF SHOWER
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
FI990937A0 (en) The line of subscriber
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
ID30023A (en) COMBINATION OF FUNICIDE ACTIVITIES
PT1178984E (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME
NO20014845D0 (en) Use of arylalkanoylpyridazines
PT1175417E (en) SUBSTITUTED COMPOUNDS OF BENZOLACTAMAS
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
NO20016030L (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homothylosin
NO20021234D0 (en) Use of thienopyrimidines
NO20005856D0 (en) Use of 1,1-dioxo-perhydro-1,2,4-thiadiazines
SE9902239D0 (en) Kornisch consisting of several parts
SE9903009D0 (en) Use of new responsive elements
SE9904269D0 (en) Use of new responsive elements
ITMI20000412A0 (en) SHOWER

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application